scholarly journals Clinical impact of in-stent late loss after drug-eluting coronary stent implantation†

2007 ◽  
Vol 28 (13) ◽  
pp. 1583-1591 ◽  
Author(s):  
Raúl Moreno ◽  
Cristina Fernandez ◽  
Angel Sanchez-Recalde ◽  
Guillermo Galeote ◽  
Luis Calvo ◽  
...  
Author(s):  
Adeyemi Iyanoye ◽  
Sampada K Gandhi ◽  
Edith Zang ◽  
Javier Cabrera ◽  
Nora M Cosgrove ◽  
...  

Background: Women are less likely than men to have cardiac catheterization and percutaneous coronary intervention (PCI) after acute myocardial infarction (AMI). It is unclear whether such gender disparity extends to the implantation of the type of coronary stent (bare metal stent (BMS) versus drug eluting stent (DES)) after AMI. Methods: We examined coronary stent implantation by type within 30 days of AMI in 33,748 patients admitted to non-federal hospitals in New Jersey using a statewide database. Data from 2003 through 2009 in the Myocardial Infarction Data Acquisition System (MIDAS) were used to identify patients with first episode of AMI and single type (BMS versus DES) of coronary stent implantation after the AMI. Multivariate logistic regression was used to analyze the differences by gender after adjustment for age, race, insurance, site of MI, pre-or post discharge stent implantation, and co-morbidities. Results: Coronary stent implantations after AMI were stratified by placement periods into: at index of AMI admission, n=16,719; within 2 days, n=22,019; within one week, n=31,618; and within 30 days of index AMI, n=33,748. In 2003, the use of BMS in women declined from 76% (386 of 507) to 68% (986 of 1454) from index AMI to 30 days, and in men from 79% (930 of 1181) to 70% (2017 of 2863). The use of DES in women increased from 24% (121 of 507) at index AMI to 32% (468 of 1454) at 30 days, and in men from 21% (251 of 1181) to 30% (846 of 2863). After adjustment for covariates, in 2003, women were more likely to receive DES than men within 2 days of the index AMI [Odds Ratio (OR): 1.37; 95% Confidence Interval (CI): (1.10, 1.70); p = 0.005], within 1 week of index AMI [OR: 1.21; CI (1.03,1.41); p= 0.02], within 30 days of index AMI [OR: 1.20; CI (1.03, 1.39); p = 0.02)]. In 2004 through 2009, both men and women had higher proportion of DES than BMS implantation after AMI. However, there was no significant gender difference in stent type for these years, except in 2006 when DES implants (received within 1 week and 30 days of index AMI) were significantly more frequent in women compared to men. Conclusion: Although women are less likely to receive PCI compared to men after AMI, there is generally no gender difference in the proportion of DES versus BMS received in contemporary years.


2011 ◽  
Vol 107 (8) ◽  
pp. 44A
Author(s):  
Kenji Sadamatsu ◽  
Masataka Ikeda ◽  
Nobuhiro Honda ◽  
Yasuaki Koga ◽  
Kaori Oba ◽  
...  

2020 ◽  
Vol 41 (Supplement_2) ◽  
Author(s):  
Y Nakano ◽  
T Onishi ◽  
M Suzuki ◽  
T Niwa ◽  
K Mukai ◽  
...  

Abstract Background Triglyceride deposit cardiomyovasculopathy (TGCV) is a novel cardiovascular disorder, encoded as orphan disease in Europe in 2019, characterized by excessive accumulation of triglyceride in vascular smooth muscle cells, leading to coronary artery disease (CAD). However, there is no data about impact of TGCV on vascular failure after coronary stent implantation. Purpose To assess impact of TGCV on the outcome following coronary stent implantation in CAD patients with diabetes mellitus (DM) as Study 1, and chronic hemodialysis as Study 2. Methods This is multicenter retrospective estimation consisting of two studies. Study 1) Among 526 consecutive patients suspected of having CAD who underwent coronary angiography (CAG) and iodine-123-β-methyliodophenyl-pentadecanoic acid (BMIPP) scintigraphy, a tracer for the diagnosis of TGCV, data from 81 patients with DM were analyzed. The patients were divided into two groups; TGCV (n=7) or non-TGCV (n=74). All patients were implanted with a second-generation DES and underwent follow-up CAG. Binary restenosis (ISR), defined as angiographic luminal diameter >50% by quantitative coronary angiography, in-stent late loss were assessed in 15 stents of TGCV patients and 111 stents of non-TGCV patients. Study 2) Similarly, among 88 chronic hemodialysis patients, ISR and in-stent late loss were assessed in 12 stents of 9 TGCV patients and 21 stents of 17 non-TGCV patients. Results Study 1) There were no significant differences in baseline characteristics between the two groups. In-stent late loss was greater in TGCV group than in non-TGCV group (0.91mm [0.27, 2.39] vs. 0.15mm [0.03, 0.35]; p<0.001), resulting in greater incidence of ISR in TGCV group than in non-TGCV group (46.7% vs. 9.0%; p<0.001). Multivariable logistic analysis revealed TGCV to be an independent predictor for vascular failure after DES implantation in patients with DM. Study 2) Similarly, in-stent late loss and incidence of ISR were greater in TGCV group than in non-TGCV group (1.20±0.99mm vs. 0.50±0.70, p=0.02; 58.3% vs. 9.5%, p=0.002, respectively). TGCV was an independent predictor for vascular failure after DES implantation in chronic hemodialysis patients. Conclusion Apart from existing risk factors such as DM and hemodialysis, TGCV could contribute to a novel risk factor for vascular failure, even in the second-generation DES era. Figure 1 Funding Acknowledgement Type of funding source: None


2013 ◽  
Vol 166 (2) ◽  
pp. e31-e32
Author(s):  
Kazuhiro Yajima ◽  
Kazuko Watanabe ◽  
Kento Mori ◽  
Norihiro Yoshimura ◽  
Hiroaki Yamashita ◽  
...  

Author(s):  
Rose Mary Ferreira Lisboa da Silva ◽  
Carlos Augusto Bueno Silva ◽  
Otaviano José Greco ◽  
Maria da Consolação Vieira Moreira

2005 ◽  
Vol 45 (8) ◽  
pp. 1193-1200 ◽  
Author(s):  
Stephen G. Ellis ◽  
Jeffrey J. Popma ◽  
John M. Lasala ◽  
Joerg J. Koglin ◽  
David A. Cox ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document